Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endothelial Degeneration”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Not applicableStudy completedNCT05603429
What this trial is testing

Investigation of Myocardial Protection Level With Specific Cardioplegia Methods in Cardiac Surgery

Who this might be right for
Bypass ComplicationCardioplegia Solution Adverse ReactionEndothelial Degeneration+3 more
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital 74
Large-scale testing (Phase 3)Study completedNCT06270836
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Who this might be right for
Diabetic Retinopathy
Kodiak Sciences Inc 255
Not applicableStudy completedNCT05640895
What this trial is testing

Intravitreal Injection Site and Perceived Pain

Who this might be right for
Pain
The University of Texas Medical Branch, Galveston 53
Large-scale testing (Phase 3)Ended earlyNCT04296838
What this trial is testing

Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF

Who this might be right for
UveitisMacular EdemaVascular Endothelial Growth Factor+1 more
Peking Union Medical College Hospital 5
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Post-approval studies (Phase 4)Study completedNCT02125864
What this trial is testing

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept

Who this might be right for
Exudative Age-related Macular Degeneration
Oslo University Hospital 16
Not applicableEnded earlyNCT00709657
What this trial is testing

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Who this might be right for
Macular DegenerationRegional Blood FlowVascular Endothelial Growth Factor
Medical University of Vienna 8
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Not applicableStudy completedNCT04351113
What this trial is testing

Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse

Who this might be right for
AgingOxidative StressVascular Endothelium+2 more
Joel Trinity 82
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Large-scale testing (Phase 3)Ended earlyNCT04611152
What this trial is testing

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 460
Not applicableUnknownNCT05759884
What this trial is testing

Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema

Who this might be right for
Macular Edema Due to Type 2 Diabetes Mellitus
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Not applicableEnded earlyNCT04527523
What this trial is testing

Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only

Who this might be right for
Cystoid Macular EdemaFuchs Dystrophy
Wake Forest University Health Sciences 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Large-scale testing (Phase 3)UnknownNCT02296567
What this trial is testing

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

Who this might be right for
Age Related Macular Degeneration
East Florida Eye Institute 80
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Early research (Phase 1)Study completedNCT03835884
What this trial is testing

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Aerie Pharmaceuticals 18
Large-scale testing (Phase 3)Study completedNCT01012973
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Bayer 177
Post-approval studies (Phase 4)Study completedNCT01988662
What this trial is testing

UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)

Who this might be right for
Neovacular Age-related Macular Degeneration
Novartis Pharmaceuticals 205
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Next Page